| Financial Year |
March 31 2023 |
| Monetary Funds |
449,073,416.70 |
| Held-for-trading Financial Assets |
22,015,311.08 |
| Notes Receivable |
52,281,753.38 |
| Accounts Receivable |
286,311,553.42 |
| Advances to Suppliers |
174,741,648.86 |
| Other Receivables |
7,920,179.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
257,489,644.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,860,954.71 |
| Total Current Assets |
1,462,404,014.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
628,938.69 |
| Investment Properties |
-- |
| Fixed Assetes |
707,978,560.20 |
| Under-construction Projects |
259,541,144.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,633,799.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
15,407,491.97 |
| Other Non-Current Assets |
4,152,879.97 |
| Sub-Total of Non-Current Assets |
1,208,793,643.53 |
| Total Assets |
2,671,197,657.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
760,416.00 |
| Notes Payable |
25,999,910.20 |
| Accounts Payable |
471,843,149.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,865,613.28 |
| Taxes Payable |
24,600,467.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
573,833.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,588,355.32 |
| Other Current Liabilities |
2,683,558.22 |
| Sub-Total of Current Liabilities |
1,006,452,914.13 |
| Long-term Loans |
158,754,273.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
246,987.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
174,900,709.91 |
| Total Liabilities |
1,181,353,624.04 |
| Paid-In Capital(Or Share Stock) |
449,070,000.00 |
| Capital Surplus |
424,327,481.51 |
| Surplus Reserve |
46,673,676.06 |
| LESS:Treasury Stock |
28,752,150.45 |
| Undistributed Profits |
597,241,404.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,489,844,033.66 |
| Owner's Equity（Stockholder's Equity） |
1,489,844,033.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,671,197,657.69 |
